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Abstract
The obesity epidemic has driven the search for dietary interventions for weight reduction.
In the current study we determined the role of dietary composition and also timing of
feeding on weight loss, with a specific focus on changes in intestinal parameters. Mice
were divided into different groups with different feeding protocols. Dietary interventions
altered weight gain and body composition and intestinal parameters including small
intestinal length and cecum weight. There was no difference in splenic or colonic B and T
cell populations, but regulatory T cells numbers were altered with the vegan-based diet.
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INTRODUCTION
The human intestinal microbiota is complex as it comprises hundreds of bacterial species.
To be precise, adults have approximately 250 ml colonic contents, with 1011 bacterial
cells per ml. The collective genome of these organisms is at least 100 times that of the
eukaryotic genome. Modern molecular biology methodologies helped us to understand
the colonic microbial composition and hence having a better understanding of colon’s
dominant phyla (Gijs Den Besten et al. 2013; Byrne et al. 2015; Kasubuchi et al. 2015;
Kimura et al. 2013). These microbes help the host by providing protection against
pathogens, enhancing the metabolic capabilities, modulating gastrointestinal (GI)
development and educating the immune system. Although there are variations in number,
type and function of microbes along the length of GI tract, most are concentrated within
large bowel where their primary role is fermentation of undigested food components like
carbohydrate/fiber. Bifidobacterium, Lactobacillus, Bacteroides, Clostridium,
Escherichia, Streptococcus and Ruminococcus are the most common gut bacteria in
adults. Of these, Bacteroidetes or Firmicutes phyla constitute the 60% of the bacteria
found (Manichanh et al. 2006). Comparing the microbiome of subjects who consume
diets high in fiber or high in animal fat and protein, it has been found that long term
dietary habits influence the intestinal microbiota composition. Currently we do not fully
comprehend the impact of the environment and dietary habits of modern humans on the
microbial ecology of the human gut (De Filippo et al. 2010).
In the US, many chronic diseases are related to diet, including cardiovascular disease,
hypertension, and diabetes mellitus. This diet is typically high in fat and simple
carbohydrates (Cordain et al. 2005). Recent lifestyle innovation has definitely raised
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concerns particularly regarding the Western diet’s role in alteration of genetic
composition as well as metabolic activity of our resident gut microbiota (Conlon and Bird
2015)(David et al. 2014b). Growing epidemics of chronic illness in the developed world,
including obesity and inflammatory bowel disease, are suspected to be related to changes
in gut-associated microbial communities induced by such diets. It is still unclear how diet
alters specific bacterial communities. It had been found that the gut microbiome of mice
was altered as early as a single day after dietary macronutrients were shifted (Faith et al.
2012)(Turnbaugh et al. 2009). But in contrast, studies of dietary interventions in human
cohorts measuring community changes after weeks or months of intervention failed to
find significant diet-specific effects, or else have demonstrated responses among a limited
number of bacterial taxa (David et al. 2014a).

Interaction of Microbiome with Diet
Commensal bacteria play a key part in the digestion of food. For example, specific species
including Bacteroides spp., Eubacterium spp., Bifidobacterium spp., Fusobacterium spp.,
Peptostreptococcus spp. help to extract nutrients and generate metabolites that are
beneficial for the host. These nutrients and metabolites are implicated in homeostasis and
the development and functioning of the immune system. The gut microbiome therefore
plays an instrumental role in host immunity through the nutrients and metabolite dependent
mechanisms (Manuscript 2014) (Artis 2008).
Obesity has become an enormous public health concern due to its role in the development
of many chronic diseases. In the US, the prevalence of obesity has increased by more
than 75 % over the course of last 25 years. Two thirds of the current US population is
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overweight and 1 in 3 adults are found to be clinically obese in the present scenario
(Dibaise, Frank, and Mathur 2012). It is now well accepted that obesity and its associated
low grade chronic inflammation can contribute to the development of insulin resistance
and type 2 diabetes and other detrimental health consequences(Wellen and Hotamisligil
2005) (Jung and Choi 2014). Previous studies focused on adipose tissue as the source of
obesity-associated inflammation, but recent evidence support the idea that inflammation
associated with diet-induced obesity (DIO) is linked to intestinal bacteria (Ding et al.
2010). The gut microbiome has therefore become important target for dietary
interventions and pharmacologic agents. Currently, no direct association of specific
microbes with obesity has been observed. It is complicated by the fact that both dietary
intake and the host’s genetic variation has an influence on gut microbiota’s structure as
well as phenotype (Clemente, Clemente, and Garc 2017).

Factors affecting gut microbiota composition
Factors such as diet, medication, probiotics, host’s genetics and environmental factors
influence the composition of gut microbiota. Of these factors, diet is main factor driving
the colonic bacteria (Laparra and Sanz 2010)(Xiao et al. 2017). As high as 57 % of the
variation in microbiota attributed dietary changes as compared to genetic variation
accounting to only 12% (Baothman et al. 2016). People around the world have long been
consuming probiotics in their diet as different fermented foods and increasing the
number of health-promoting bacterialike Lactobacilli and Bifidobacteria species
positively changes the microbiota balance and increases beneficial metabolites and short
chain fatty acids (Arora, Singh, and Sharma 2013).
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Production of SCFAs by Gut Microbiota
A major function of the intestinal gut microbiota is fermentation of carbohydrates and
proteins that escape digestion in the small intestine. Amongst the wide range of
metabolites produced by the microbiota are short chain fatty acids (SCFA)(Scheppach
1994)(Morrison and Preston 2016). These molecules are characterized by containing
fewer than six carbons, existing in straight, and branched-chain conformation and are
volatile fatty acids. The most abundant (90–95%) of SCFA present in colon are acetic
acid (C2), propionic acid (C3), and butyric acid (C4). Although carbohydrates (CHO) are
the main substrate for SCFA generation, amino acids such as valine, leucine, and
isoleucine can also be converted into branched-chain SCFA (BSCFA) that includes
isobutyrate, isovalerate, and 2-methyl butyrate and form a minor (5%) source of SCFA
(Ríos-covián et al. 2016) (C. Kim et al. 2014)(Sun et al. 2017).
SCFA have several functions within the host’s body including being a source of energy.
It has been found that the SCFA provide around 10 percent of the total daily calorific
requirement for humans (Gijs Den Besten et al. 2013). It has been also observed that the
SCFA can reduce cholesterol levels. (Gijs Den Besten et al. 2013)(Fushimi et al. 2017).
Additional functions include influencing colonic mobility, and blood flow, and altering
gastrointestinal pH (Tazoe, H., Otomo, Y., Kaji, I., Tanaka, R., Karaki, S. I., & Kuwahara
2008).
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Impact of Diet on Gut Microbiota Composition and SCFA Production
Changes in the composition of gut microbiota are driven by changes in diet, the host
genetic background and the colonic milieu. The colonic milieu is also in turn affected by
microbial activity. This leads to the variation of the microbial population between
individuals (Gijs Den Besten et al. 2013)
The composition and activities of gut microbiota are strongly affected by diet and these
impact the health of the host (Rajoka et al. 2017) (Graf et al. 2015) (G. D. Wu et al.
2011).The amount and types of fiber consumed have dramatic effects on the composition
of the intestinal microbiota and consequently on the type and amount of SCFAs produced
(G den Besten et al. 2013). Short-term diet changes have also been shown to alter the
human gut microbiome has also been demonstrated (Ríos-covián et al. 2016). A high
fiber dietary pattern with subsequent and consistent production of SCFAs with a healthy
gut microbiota results in a reduced risk of advanced colorectal adenoma (Chen et al.
2013). It has also been found that prebiotic substrates, that selectively improve the
growth of beneficial microbiota like Bifidobacterium and Lactobacillus, induce changes
in SCFA production by the microbiota of healthy individuals by protecting against a
range of chronic diseases like CRC, IBD, type 2 diabetes (Majid, Emery, and Whelan
2011)(Conlon and Bird 2015). Besides diets and probiotic substrate, the dairy products
fermented with beneficial bacteria also modify the intestinal microbiota toward more
butyrate producers in comparison to chemically-acidified milk (Ríos-covián et al. 2016)
(Veiga et al. 2014).
In a study of overweight and obese population’s dietary intervention, high levels of fecal
SCFA related with obesity status(Schwiertz et al. 2010). Although it was reported
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initially that high-fat feeding and obesity were associated with lower ratios of
Bacteroidetes relative to Firmicutes, subsequent studies challenged this association
(Murphy, Velazquez, and Herbert 2015). Obesity, as indicated by recent studies, is in fact
correlated with decreased microbial diversity. As illustrated in gut microbiota profiles in
TLR5 knockout mice, TLR2 knockout mice, NOD mice, ob/ob mice, and db/db mice
compared with wild-type mice, the composition of the gut microbiota was modulated by
genetic background (Harris et al. 2012). Observed changes in the gut microbiota in these
mouse models may also be induced by altering the food intake. In some cases, phenotype
similarity was found when microbiota was transplanted from knockout mice into wildtype recipient (Montgomery et al. 2013). The strongest drivers for gut microbial
composition in humans and mice is thought to be long term habitual dietary intake
including fat (Murphy, Velazquez, and Herbert 2015). Because fat also determines the
obesity development, it is not understood if the changes in microbiota are due to obese
state or from HF feeding based on commonly used models. Most commonly used strains
to study genetic and diet-induced obesity are the obesity prone C57BL/6JBomTac (BL6)
mouse strain and obesity-resistant mouse strain 129S6/SvEvTac (Sv129) (Xiao et al.
2017)
The inter-relationship between diet, gut microbial ecology and energy balance was
investigated using mouse model of obesity, produced by consumption of prototypic
Western diet. Blooms in single uncultured clade within Mollicutes class of Firmicutes
was produced due to diet-induced obesity (DIO). Subsequent dietary manipulations
limiting weight gain diminished the bloom. It was observed that greater fat deposition
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occurred when germ-free recipients were transplanted with microbiota from DIO mice
rather than from lean donors (Fulton et al. 2008).

Short Chain Fatty Acids and Treg Cells
There is a close relation between nutrition and immunity. Of all the cells in the body, the
immune system has the most energy consuming cells (Wolowczuk et al. 2008)(Çehreli
2018). So, any imbalance in nutrition strongly affects immune system(Çehreli 2018).
Intestinal immune system has to evolve along with our gut microbiota in order to
maintain intestinal health. SCFAs a bacterial metabolites has been shown to have induced
Treg cells (Baothman et al. 2016). Disruption of this homeostasis results in intestinal
inflammation and inflammatory diseases such as, IBD, IBS, (Brown et al. 2012).
Through the expansion and differentiation of colonic Foxp3+ regulatory T cells (Tregs),
the mucosal immune system is regulated by gut commensal microbes (Gijs Den Besten et
al. 2013; Byrne et al. 2015; Kasubuchi et al. 2015; Kimura et al. 2013). Amongst the
CD4+ T cell population (T helper (Th) cells) CD4 effector T cells control adaptive
immunity against pathogens and cancer, while Tregs suppress potentially deleterious
activities of effector cells (Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T,
Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y 2011). Using the method of
candidate microbe approach, bacterial species and strain specific molecules affecting
intestinal immune response have been identified (H. J. Wu and Wu 2012). In a study
using mice, it was demonstrated that SCFA control the size and function of colonic Treg
pool. This population of cells can protect against colitishrough induction of Tregs there
was adaptive immune-microbiota coadaptation and promotion of colonic homeostasis and
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health (Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G,
Yamasaki S, Saito T, Ohba Y 2011). Colonic Tregs is also induced by Clostridia and has
been shown to play a vital role in suppressing inflammation as well as allergic responses,
but the molecular mechanism by which colonic Tregs are induced remains a mystery. In
mice it has been found that butyrate and propionate, microbial fermentation products, are
able to induce the differentiation of colonic Tregs. (Smith et al. 2013)
In comparison to other organs, Foxp3+ Tregs are more abundant in the gut lamina propria
(LP) of the colon. Intestinal bacteria have been postulated to affect the quantity and
function of mucosal Tregs(Geem et al. 2016). Daily treatment with probiotic strains of
bifidobacteria and lactobacilli been found to modify the inflammatory status of mice
associated with Tregs (Candelaa, M; Pernab, F; Carnevalic 2008). In addition, an
intervention using mice inoculated the human commensal Bacteroides fragilis induced
Treg differentiation and increased colonic interleukin-10 (IL-10) production(Nakanishi,
Sato, and Ohteki 2015). Although it is clear that the alteration in the indigenous microbial
flora correlates with inflammatory diseases, we have to further establish the role in the
number and functioning of mucosal Tregs (Murakami et al., n.d.).
Foxp3+ Tregs have a key role in maintaining immune homeostasis as they attenuate
immune responses. Many research groups have focused on Tregs cells over the course of
last ten years by characterizing different subsets. Helios which is the member of Ikaros
family was recently reported to be a marker that differentiate naturally occurring thyimicderived T-regs from peripherally induced naive CD4+ T cells (Akimova et al. 2011).
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Hypothesis
We hypothesize that diet composition and feeding schedule will alter microbiome
metabolites and gut-associated Tregs.

Aim 1.
To determine the amount and composition of SCFA generated in the cecum of mice
undergoing different diets and feeding protocols.

Aim 2.
To determine if different diets and feeding protocols alter the T cell repertoire,
specifically focusing on regulatory T cells associated with the large intestine.
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MATERIALS AND METHODS
4-week-old C57BL/6 male mice were purchased from Envigo. Upon their arrival, they
were co-housed 2 animals per cage in a USDA approved animal facility on the University
of Memphis campus and entrained to an alternating 12-hour dark and 12-hour light
schedule (7 pm – 7 am) for two weeks while having ad libitum access to standard rodent
chow and water. Mice were housed in an area used for circadian rhythm studies and light
was therefore well-regulated. After 2 weeks of entrainment, 8 mice remained on the chow
diet (remained on this diet for the extend of the study. Chow control), while 48 mice were
switched to a high fat diet consisting of 45% fat (mostly lard), 35% carbohydrate and
20% protein and allowed to eat ad libitum. This diet induces obesity in the C57BL/6
mouse strain. After 6 weeks of high fat feeding the mice started the intervention and were
divided into 6 groups based on diet composition (see Table 1) and feeding times as
follows:
HF – continued ad libitum access to the 45% high fat diet.
Sw-Chow – ad libitum access to the original chow diet.
DF - ad libitum access to a purified, fiber-rich, vegan-based diet.
CR - caloric restricted groups were fed the high fat diet at 80% of ad libitum of intake as
determined during week 6 of high fat feeding prior to intervention.
ADF - alternate day fasting group was fed the high fat diet but followed feeding protocol
that allowed ad libitum access to food every other day, while fasting for 24h in between
feedings.
TRF - time restricted feeding group had access to the high fat diet for 6 hours every day,
during the first half of the active (dark) phase (8 am- 2pm)

10

All groups had ad libitum access to water and remained on their respective diets for an
additional 8 weeks. Food consumption was measured daily, and mouse weight
determined every other day.
Body composition was determined by EchoMRI immediately prior to the dietary
intervention and before sacrifice.
Blood was collected via facial vein immediately prior to sacrifice. Mice were sacrificed
using isoflurane and cervical dislocation and tissues harvested immediately. Cecal
samples and small intestinal contents were collected and immediately frozen in liquid
nitrogen
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Table 1. Composition of experimental diets.
Macronutrient
Protein
Carbohydrate
Fat
kcal/gm

DF
kcal%
15
59
25

HF
CHOW
kcal% kcal%
24
20
58
35
18
45

3.9
4.73
Ingredient of DF and HF

3.1

DF
Ingredient
Casein
Soy Protein
DL-Methionine
Corn Starch
Corn Starch-Hi Maize
260
(70% Amylose and 30%
Amylopectin)
Maltodextrin
Sucrose
L-Cystine
Cellulose, BW200
Inulin
Soybean Oil
Lard
Flaxseed Oil
Safflower Oil, High Oleic
Ethoxyquin
DiCalcium Phosphate
Mineral Mix S10001
Calcium Carbonate
Mineral Mix S10026
Vitamin Mix V10001
Choline Bitartrate
Ascorbic Acid Phosphate,
33% active
Potassium Citrate, 1 H2O
Cholesterol
FD&C Red Dye #40

HF

gm
0
170
3
0

kcal
0
680
12
0

gm
200
0
0
72.8

kcal
800
0
0
291

533.5

2134

0

0

150
0
0
100
50

600
0
0
0
50

0
71
59
0.04

0
639
531
0

35
4

0
0

10
2

40
0

100
172.8
3
50
0
25
177.5
0
0
0
13
10
5.5
10
0
2

400
691
12
0
0
225
1598
0
0
0
0
40
0
0
0
0

0.41

0

0

0

0
0
0.05

0
0
0

16.5
0
0.05

0
0
0
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Table2: Chow Diet

Calcium
Phosphorous
Non-Phytate
Phosphorous
Sodium
Potassium
Chloride
Magnesium
Zinc
Mangenese
Copper
Iodine
Iron
Selenium
Vitamins
Vitamin A e,f
e,g

Vitamin D3
Vitamin E
Vitamin K3 (menadione)
Vitamin B1 (thiamin)
Vitamin B2 (riboflavin)
Niacin (nicotinic acid)
Vitamin B6 (pyridoxine)
Pantothenic Acid
Vitamin B12
(cyanocobalamin)
Biotin
Folate
Choline

%
%

Amino Acids
1 Aspartic Acid
0.7 Glutamic Acid

%
%

1.4
3.4

%

0.4 Alanine

%

1.1

%
%
%
%
%
%
%
%
%
%
%
%

0.8
0.7
1.6
1.1
1.8
0.8
0.9
1
0.6
0.4
0.3
0.9

%
%
%

0.4
1
0.2

%
%
%
%

0.7
0.2
1.2
3.1

%

0.3

%
%
%

0.9
1.3
3.4

%
%
%
%
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
IU/g

0.2
0.6
0.4
0.3
70
100
15
6
200
0.23

Glycine
Threonine
Proline
Serine
Leucine
Isoleucine
Valine
Phenylalanine
Tyrosine
Methionine
Cystine
15 Lysine

IU/g
IU/kg
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg

1.5
110
50
17
15
70
18
33

Histidine
Arginine
Tryptophan
Fatty Acids
C16:0 Palmitic
C18:0 Stearic
C18:1ω9 Oleic
C18:2ω6 Linoleic

mg/kg

0.08 C18:3ω3 Linolenic

mg/kg
0.4 Total Saturated
mg/kg
4 Total Monounsaturated
mg/kg 1200 Total Polyunsaturated
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Immune cell isolation, flow cytometry
The spleen and colon were immediately processed after harvest for immune cell isolation
and analysis. Splenocytes were isolated using a sterile 40 μm cell strainer and syringe
plunger and rinsing with RPMI 1640 (Roswell Park Memorial Institute medium) solution
containing 2% FBS (Fetal bovine serum). Cells were pelleted with centrifugation and
media removed. Cell pellet were suspended in ACK (Ammonium Chloride Potassium)
lysis buffer (for red blood cell lysis) and incubated at room temperature for 2 minutes and
the suspension were diluted with RPMI 1640 containing 2% FBS. Cells were washed
with PBS containing 2% FBS and finally resuspended in 2-3ml PBS with 2% FBS. Live
cells were quantified using Trypan Blue and a hemocytometer.
The colon were isolated from cecum to rectum and contents gently removed. Individual
colons were cut open longitudinally washed in RPMI/10%FBS/1 mM HEPES (N-2hydroxyethylpiperazine-N -2-ethanesulfonic acid; RPMI-10/HEPES) and cut into 5 mm
sections followed by 6 washes in RPMI-10/HEPES. To obtain single-cell suspensions,
colon sections were incubated in two serials 1-hour digestions in collagenase-E (95
IU/mL; Sigma-Aldrich, St Louis, MO). After the final incubation, the tissue was sheared
using a 30 ml syringe with 16 gauge needle. In order to homogenize, the tissue fragments
were aspirated continuously. The homogenate were passed over a 40 μm cell strainer and
the cells were pelleted by centrifugation at 1500 rpm at 4°C for 5 minutes. Cells were
resuspended in 44% Percoll that is overplayed onto 66% Percoll and spun at 2300 rpm
for 20 minutes at room temperature to enrich the mononuclear cells. A band of white
blood cell collected and transferred to a 15-ml conical tube and the cells were washed

14

with PBS with 2% FBS. The cells were resuspended in PBS with 2% FBS and counted as
mentioned previously.
Cells isolated from spleen and colon were incubated with Trustain FcX (Biolegend, San
Diego)
to block Fc receptors. Cells were then stained with the following fluorescently
conjugated antibodies for identification: PeCY7 anti-mouse CD 3 (clone- 145-2C11,
Biolegend), APC anti-mouse CD4 (clone GK 1.5), PacBlue anti-mouse CD8α (Clone53-6.7, Biolegend), PE anti-mouse TCR β-chain (clone H57-597, Biolegend), PacBlue
anti-mouse/human Helios (clone-22F6, Biolegend), PE Anti-mouse/Rat FOXP3 (clone
FJK-16s, eBioscience). Dead cells were excluded using LIVE/DEAD™ Fixable Aqua
(Life Technologies, Eugene, OR). After staining all samples were fixed by incubating
with Fixation/Permeabilization solution (eBioscience, San Diego, CA) overnight at 4˚C
according to the manufacturer’s instructions.
Foxp3 intracellular staining was perform after fixation/permeabilization.
All samples were analyzed using an Invitrogen “Attune” NxT Flow Cytometer
(ThermoFisher Scientific, Waltham, MA). The data obtained were further analyzed using
FlowJo software (FlowJo LLC, Ashland, OR).
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SCFA Analysis, Ion Chromatography
Ion chromatography (Dionex) is composed of GP50 gradient pump with AG15 guard
column, AS15 analytical column and ED50 electrochemical detector.
Cecum contents were collected and immediately frozen in liquid nitrogen and store at 80°C until analysis. For analysis the samples were thawed, and weight recorded. 10 ml of
dilute H2SO4 (0.18M; 1:100 dilution of H2SO4 stock (36 Normality)was added to cecum
sample weighing more than 60mg and 5ml dilute H2SO4 for samples weighing less than
60 mg. The sample were sonicated for one minute, while being kept on ice. The
suspension was further diluted to 10 % in a labeled microfuge tube by pipetting 100µL
sample and 900µL of the dilute H2SO4 and then centrifuged at 1400 rpm speed for 10
minutes. A disposable transfer pipette was used to place the supernatant in a 3 mL
syringe with attached 0.2µL filter. Using the syringe, the contents were transferred into a
labeled glass AS50 auto-sampler vials for analysis by ion chromatography was
programmed by injecting 200 µl of each sample. For eluent, 100mM eluent (KOH) was
used. Acetate, lactate, proprionate, chloride, formate and isobutyrate, butyrate were used
as standards.

Statistical Methods
All data are presented as means ± SEM and statistical significance was established at P <
0.05. One-way analysis of variance (ANOVA) and post-test Tukey were used to compare
group means. For weight data a two-way ANOVA with Tukey’s multiple comparison test
was performed. All statistical analysis was performed with Graph Pad Prism Software
(Version 7, San Diego, CA)
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RESULTS
Food consumption, body weight and body mass and composition
Food consumption and body mass of all animals were monitored during the intervention.
All high fat groups consumed similar amounts (in grams) of food, while a higher volume
of the less energy dense diets were consumed by the Chow and DF groups (CH 3.7g, HF
2.7gm SW-CH 3.5g, DF 3.5g, CR 2.3g, ADF 2.0g, TRF 2.2g Figure 1A demonstrate
average daily calorie consumption over the 8 weeks period of the intervention. When
calculating the average daily calorie consumption for the study, the HF and DF groups
consumed significantly more calories per day than any of the other groups (Fig. 1B, P<
0.001)
After the 3rd week of the intervention there was a significance increase in the weight of
the HF group (Figure 1C, P < 0.0001) with the high fat group having the highest body
mass at the end of intervention (Chow 27.71g ±3.13, HF 39.56g ±4.9, Sw-Chow 28.7g
±2.4, DF 28.9g ±1.4, CR 33.85g ±2.8, ADF 28.68g ±1.2, TRF 28.54g ±1.7). Weight
change was determined over the 8 week intervention period and the HF group gained
significantly more weight during the 8 weeks compared to all other groups (Figure 1D, P
< 0.0001). Interestingly, the Sw-Chow group lost significantly more weight than the CR
group, despite consuming an equal amount of calories (P= 0.0003).
To determine if weight loss was due to loss in fat or lean mass, body composition was
determined at the beginning and end of intervention. The greatest difference in body fat
was induced by the low-fat diets (Figure C, HF +6.8g ± 1.3, SW-CH -6.23g ± 2.4, DF 4.1g ± 1.3; HF vs DF or Sw-Chow, P<0.0001). The restricted high fat diet groups also
had significantly less body fat, albeit not to the extent of the low-fat diets (Figure 1E, HF
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+6.8g ± 1.3, CR 0.01g ±1.26, ADF -2.4g ±1.5, TRF -1.8g ± 1.7, HF vs CR, ADF or TRF,
P<0.0001). Despite the reduced fat, the low-fat diets maintained nonfat/lean (Figure 1F).
Figure 1
A.

B.

C.

D.

E.

F.
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Figure 1. Food consumption (A) and body mass were monitored every day and other
day respectively during the 8 week intervention. (B)_Average daily kcalorie
consumption was calculated, P≤0.002 Bars without a common letter differed
sifnificantly (C) After weeks on respective diets the HF group differed from all
groups, P<0.001 (D) Body weight difference was calculated from pre-and postintervention weight, P<0.0001(E) Fat and (F) Lean mass difference pre- and postintervention P > 0.9 Bars without a common letter differed significantly. All values
are mean ±SEM. N=7-9.
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Changes in intestinal parameters
After euthanasia intestines were immediately removed from stomach to rectum. The
length of the small intestine and colon were measured, and cecum weighed. There was a
significant reduction in total intestinal length of all in the groups consuming the high fat
diets compared to the Chow control (Chow 48.2cm ±2.051, HF 43.86cm ±2.201, SwChow 46.76cm ±3.78, DF 47.25cm ±1.069, CR 44.53cm ±2.047, ADF 43.69cm ±1.29,
and TRF 42.88cm ±1.82; Figure 2A, Chow vs HF, CR, ADF or TRF, P < 0.03), while no
difference was observed in intestinal length of when consuming the low fat diets (Chow
vs Sw-Chow or DF, P>0.2). This trend was consistent for the small intestinal length
(Chow 39.4cm ±2.4, HF 35.86cm ±2.5 Sw-Chow 37.14cm ±2.4, DF 38.03cm±1.1, CR
36.09cm ±1.9, ADF 35.28c ± 1.0, TRF 34.64cm ± 1.3, Figure 2B, Chow vs HF, CR, ADF
or TRF, P < 0.02, Chow vs Sw-Chow or DF, P>0.3). The only significant difference
observed in the colon length was between the low-fat diets (DF and Sw-Chow) vs TRF
(Figure 2C, P≤0.02).
Cecum weight was increased in all low fat dietary groups (Chow 0.4g ± 0.03, HF 0.1g ±
0.05, Sw-chow 0.4g ± 0.1, DF 0.4g ±0.07,CR 0.1g ±0.03, ADF 0.1g ±0.02, TRF 0.1g
±0.01, Figure 2D, P<0.0001) with no difference in cecum weight between groups
consuming the high fat diet (P≥0.9)
Mice fed the low-fat diets (chow, switch to chow and DF) had heavier cecal (0.4± 0.04,
0.4 ± 0.1, and 0.4± 0.07). While the High Fat groups (HF, CR, ADF, TRF) showed
decreased cecal weight (HF 0.15g ±0.06, CR 0.15g ± 0.03, ADF 0.18 ± 0.02, TRF 0.15g
± 0.02,) [Fig. 2) A, B C and D]
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Diet components alters Short Chain Fatty Acids (SCFA) amount and composition
Cecal contents were harvested and microbial metabolites identified using ion
chromatography. Short fatty acids (SCFA) measured included acetate, butyrate and
propionate. No iso-butyrate was detected. Lactate was also measured. There was a trend
towards an increase in the total amount of fatty acids and lactate in all the groups fed the
high fat diet (Figure 3A, Chow 165.6nmol/mg ±28.67, HF 380.9 nmol/mg ±225.2, SwChow 195.6nmol/mg ±66.34, DF 190.7 nmol/mg ±30.4, CR 390.7 nmol/mg ±149.1, ADF
262.5 nmol/mg ±74.1, TRF 490.7nmol/mg ±356.4]), but only the TRF group showed a
significant increase compared to the lower fat diets (Figure 3A, P<0.02).. The
concentration for each SCFA and lactate were as follows in table 3:
Table 3:
SCFA
Acetate

Chow
HF
SW-CH
DF
CR
ADF
TRF
48.2±1 77.1±19. 48±17.2 42.6±5. 65.0±33. 63.7±13. 83.4±57.
1.5
9
8
0
2
1
Lactate 69.3±1 163.7±10 79.2±23. 77.9±1 218.3±10 127.2±6 269.7±2
42
9.2
0
0.4
0.8
2.2
0.0
Butyrate 23.5±1 65.6±53. 35.6±26. 36.4±2 47.4±35. 25.7±13. 56.0±57.
5.1
3
7
7.6
2
02
8
Propion 6.0±2.7 5.3±2.1
8.2±3.1 9.6±2.6 5.7±2.2
7.0±2.9 5.5±1.8
ate
Formate 18.6±6. 69.2±75. 24.62±1 24.2±4. 54.2±24. 29.5±10. 76.05±7
4
9
1.7
5
5
7
1.8
The percentage of Lactate, Acetate and Butyrate (Figure 3B) did not differ significantly
(P≥0.9) although all groups consuming the high fat diet under restricted conditions
appear to increase lactate (Figure 3C), with decreased acetate (Figure 3D) and butyrate
(Figure 3E) with the ADF groups having the least amount of change. However,
propionate was significantly increased in the low-fat diets (Sw-Chow and DF) vs all high
fat fed groups (Figure 3F, P<0.02)
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a) Total amount of short fatty acids (SCFA, includes acetate butyrate, formate and propionate.
No isobutyrate was detected in any sample) measured in cecal contents. DF and Chow diets
differed from TRF group. *P≤0.02, N=7-9. b) Representation of relative amounts of SCFA and
lactate within cecal contents. c) Lactate, Acetate, Butyrate and Propionate percentages of total
amount determined. Only propionate showed significant differences between low and high fat
diets. Bars without common letter differed, P<0.02. All values are mean ±SEM. N=7-9.
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Colonic Foxp3+Tregs are increased in the purified diet vs restricted high fat diets
Colonic immune cells were isolated from spleen and colon and lymphocyte population
determined. There was no difference in overall CD4+/CD8+ composition in the spleen
and colon (Figure 4B) Absolute cell number, and specifically CD4+ T cells were
increased in the DF group vs the ADF group (P<0.05). Foxp3_ regulatory T cells were
also significantly increased vs the ADF and TRF groups (P<0.05).
Figure 4:
A.

B.
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DISCUSSION
A recent report indicates that obesity is still increasing. Almost 64.1% and 72.3% of
American women and men are categorized as obese or overweight (Huang et al. 2015).
Due to this epidemic, many types of dietary interventions are being explored for weight
reduction.
In human studies it has been found that the diversity of microbiota is decreased and that
the ratio of Bacteroidetes/Firmicutes phyla are altered in obese individuals. This change
in the microbiota to an ‘obese microbiome’ results in increased dietary energy harvest
and favor weight gain and fat deposition. (Q. Li et al. 2017). This avenue of research is
relatively new and available data are conflicting, but the results provide an exciting
perspective. Manipulation of the gut microbiota has now become one viable avenue to
combat obesity and improve health. (Koliada et al. 2017).
It is well understood that differences in dietary composition alter the intestinal
microbiome as demonstrated by people that have diets high in either protein or
carbohydrates (Madsen et al. 2017). The nutrient source allows specific bacteria to
flourish. More recent data also suggest that different feeding protocols, such as
intermittent fasting has health benefits through alterations in gut microbiota (G. Li et al.
2017). In this current study, we used a murine model to explore the role of various dietary
interventions, both alterations in diet composition and restricted feeding protocols, on
weight, intestinal microbial metabolites and intestinal immune populations. Mice were
fed a high fat diet for six weeks to induce weight gain. At the end of six weeks, the mice
were divided into various groups that received either a different diet (lower in fat, higher
in carbohydrates) or remained on the same high fat diet, but with restriction in either
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amount or time to eat. Time restricted groups followed one of two protocols; an alternate
day feeding protocol, or they were only allowed ad libitum food access for six hours
every day. Food consumption and body weight were followed for 8 weeks at which point
the animals were sacrificed and intestinal parameters determined. All mice on
intervention diets lost weight during the 8 weeks, while the group that had ad libitum
access to the high fat diet gained approximately 20% of its starting weight. Interestingly,
the groups that were calorie restricted lost less weight than other groups, while
consuming a similar number of calories. Of importance also, the vegan-based diet (DF)
consumed the same amount of calories as the ad libitum fed high fat group but lost the
most weight (similar to the group that was switched back to the chow diet). This weight
loss was not due to loss of lean mass as the groups consuming the lower fat diet lost the
most fat mass while maintaining nonfat/lean mass.
It is known that diets with a higher fiber content result in increased intestinal length (G.
D. Wu et al. 2016). Consistent with this result, mice fed the chow or DF diet had longer
intestines, with changes both in the small intestine and colon. There was also a significant
increase in the cecum weight in the groups fed the chow diet and DF, while all groups
consuming the high fat diet (irrespective of restrictions) had the same cecum weight.
Very little is known about the impact of diet on the metabolic potential of gut microbiota
even though many studies indicated that dietary changes alter microbial activity. It was
reported that a high fat diet causes major alterations in cecal bacterial physiology and
metabolite landscape (Daniel et al. 2014). The intestinal immune system has coevolved
with the gut microbiota for the maintenance of intestinal health (H. J. Wu and Wu 2012).
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The interplay between the immune response and the gut microbiota is complex and is
essential for the proper development of the immune system, possibly through the
production of SCFA. Disruption of this homeostasis can lead to intestinal inflammation
and disease (Kosiewicz et al. 2014). Diet affects the gut microbial composition and activity,
and therefore the profile of SCFA synthesized.
To explore the immunoregulatory functions of SCFAs, several studies have been done to
analyze SCFA composition in cecal content either between specific-pathogen free (SPF)
mice and GF mice or between mice fed with high-fiber diets and low-fiber diets (D. Kim,
Zeng, and Núñez 2017). They have reported that acetate, butyrate and propionate are the
major bacteria-derived SCFAs that control the mucosal function and also Treg
differentiation (Manuscript and Magnitude 2013). There was decrease in SCFA
(propionic acid, acetic acid, butyric acid) which was related with a decrease in the
number of thymic Treg cells, and treatment with SCFA increased the number of these
cells (Çehreli 2018). Acetate is the most abundant SCFA in the colon and it makes up
more than half of the total SCFA detected in feces (Louis et al. 2007). In our study, we
measured cecum contained short chain fatty acids (SCFA) and we found all high fat
dietary groups had increased levels of total SCFA with propionate higher in mice fed the
DF and chow diets.
Propionate and butyrate metabolism have received much attention during the last years
due to the association between low levels of butyrate and propionate producers and
inflammatory diseases, for instance, butyrate producers are normally low in ulcerative
colitis (Gijs Den Besten et al. 2013).
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Tregs are a subpopulation of CD4+ T cells and can suppress other immune population
and the differentiation of colonic Tregs are promoted by specific SCFA. Of three main
short chain fatty acids. Butyrate has been found to be the most potent inducer of colonic
Tregs (Morrison and Preston 2016) (Luu, Steinhoff, and Visekruna 2017). In a recent
study it has been found that SCFAs have a role in colonic regulatory Treg homeostasis.
SCFAs did so through Treg-intrinsic expression of GPR43 (Shapiro et al. 2014) .
Colonic regulatory T cells expressing the transcription factor Foxp3 are critical for
limiting intestinal inflammation and depend on microbiota-derived signals for proper
development and function Bacteroides fragilis and clostridial species induce responses
although gut microbiota affect Tregs responses across mammalian hosts remains still
unclear(Corrêa et al. 2016).
In our study we have found that there was an increase in absolute number of
lymphocytes, with a statistical significance increase in Foxp3+ Tregs in the vegan-based
diet compared to the dietary protocols of extended fasting and high fat diet.
Also, some studies report that both microbial as well as dietary factors like probiotics
and vitamins influence the induction and suppressor functions of intestinal Foxp3+ Treg
cells (Issazadeh-Navikas and Teimer 2012). Foxp3+ Treg cells are a highly activated T
cell subset which responds rapidly to environmental and nutritional prompt. Therefore ,
appropriate nutrient supply is required to fuel the high energetic status of Foxp3+ Treg
cells for the regulation of intestinal immunity(Sakaguchi et al. 2008) (Kinoshita and
Takeda 2014) .
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CONCLUSION
This study demonstrates the reduction in calorie intake irrespective of diet composition
will result in with weight loss. We have found that the calories restriction resulted in the
smallest weight change, while the plant-based diet caused most weight loss while
consuming high amounts of calories. Also, the high fat diet resulted in increased SCFA
and lactate.
Propionic acid was increased with low fat diets. Increased levels of Foxp3 regulatory T
cells was found with the plant-based diet. The lower fat diets had a more beneficial effect
on overall health.

Recommendations for Future Research
The novel findings presented here, highlight the need for further investigation in the
effect of nutrition on the microbiome and how it relates to chronic diseases.
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IACUC PROTOCOL ACTION FORM
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IACUC PROTOCOL
FOR USE OF LIVE VERTEBRATES FOR RESEARCH, TEACHING OR DEMONSTRATION

UNIVERSITY OF MEMPHIS

5/3/17

Date submitted to Attending Veterinarian for pre-review:
5/30/17

0806

IACUC Protocol #

Date Submitted to IACUC
7/1/17

Dates Protocol will be in effect:

from

6/30/20

to

(not to exceed three years including two yearly renewals)

Is this protocol related to an external grant or contract application?
No

If yes, complete the following:

Agency:

Date Submitted

Grant #

University account for Animal Care Facility per diem charge:
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Yes

If the protocol is not related to an external grant or contract application, complete
the following:
211700

University account for Animal Care Facility per diem charge:

Project Title: (If project relates to a grant or contract application, give that title; if
multiple protocols relate to one grant, give unique titles for each protocol; if the project is
related to a class, give the course name and number):

Impact of dietary and caloric restriction models on metabolic health and physical function
in male mice

I.

Personnel
Marie van der Merwe and Richard Bloomer

Investigator/Instructor:
Health Studies

Department:
Assistant Professor and Professor

Academic Rank:

Campus phone:

678 3476 and 678 5638

Emergency phone:

Karyl Buddington

Attending Veterinarian:

42

901 406 7458 / 901 267 3514

Phone:

Emergency phone: 901-258-1232

901-678-2359

List all individuals that will handle animals using this protocol, their affiliation, and their
level of expertise (e.g. relevant qualifications). If the protocol applies to a class then so
specify.
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Marie van der Merwe, PhD (Molecular Pharmacology), Postdoctoral Fellowship (Bone
Marrow Transplantation): More than 10 years of experience using mice as a research
model.

Richard Bloomer, PhD: 2 years of prior experience using rodents in research.

Melissa Puppa, PhD: 8+ years of experience working with mice including breeding,
exercise training/testing, injections, surgery, dietary interventions, gavage, GTT,
electroporation, blood collection, and dissection/necropsy.
Matt Butawan: 2 years of rodent handling experience.
Harold Lee: 1 year of rodent handling experience, including exercise testing (treadmill
running).
Sunita Sharma: 6 months animal handling experience; has been to Laboratory Animal
Training.
Nick Smith: No experience with animals, but has been to Laboratory Animal Training;
training will be provided during experiment.
Jade Caldwell: No experience with animals, but has been to Laboratory Animal
Training; training will be provided during experiment.
Kyle Truska: No experience with animals and will attend Laboratory Animal Training;
training will be provided during experiment
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If additional personnel become involved in handling animals used in this protocol, it
is the responsibility of the principal investigator to notify the Animal Care Facility
in writing before they start.
Has the investigator/instructor and all personnel listed above received the appropriate
vaccinations (tetanus, rabies)?

Yes

No

Not

Applicable
Will be done by the time the study is initiated.
Is it necessary for personnel listed on this protocol to be tested for TB?
Yes

No

If you have questions about the kind of vaccination or about TB, call the Animal
Care Facility at 678 2359.
All U of M personnel involved in this protocol must complete the animal care and
use training program before animals can be procured or before
experiments/teaching or demonstration. In submitting this protocol, I, as Principal
Investigator/Instructor accept the responsibility for compliance with this
requirement.
In addition, the Principal Investigator/Instructor must be willing to provide
appropriate supervision for all persons working on this protocol. In the case of a
class, the Instructor must be responsible for training any students in classes
involved prior to using animals.
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II.

Project Description

A.

Summary (Enter a brief description below of your project, using lay

terminology):
Obesity has become an epidemic in the Western world, largely due to poor dietary
habits. Multiple dietary programs have been studied in recent years, showing promise
with regards to weight loss and improvement in multiple health related outcomes,
including glucose control, inflammation, and oxidative stress. More recently, a great
deal of attention has been placed on the microbiome and the influence of dietary intake
on this very important component of overall health. What is unknown is the degree of
improvement noted when following each of the popular dietary regimens as compared
to simple caloric restriction. That is, are certain protocols more beneficial than others
and if so, in regards to which specific outcome(s)? Much debate centers on these
questions and no study has sought to make direct comparisons between the wellinvestigated protocols.

In fact, most dietary protocols have simply been compared to a typical high fat
Western diet. Very few comparison studies have been conducted inclusive of the four
most common dietary approaches: Caloric Restriction (CR), Dietary Restriction (DR),
Time Restricted Feeding (TRF), and Alternate Day Fasting (ADF). The goal of the
present study is to directly compare the above four dietary plans to a Western Diet,
with regards to body mass/body fat, physical performance, insulin sensitivity,
inflammation, oxidative stress, and the microbiome. A diet of standard rodent chow
will be used as a control. Outcome measures will be determined after 8 weeks of
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assignment to the dietary programs, with a total of 56 animals assigned to one of 7 diet
groups (n=8 per group).
4 week old C57BL/6 male mice will be entrained under a 12h light: 12h dark schedule
for two weeks with standard rodent chow available ad libitum. During the entrainment
period, mice will begin the reverse light-dark schedule, with lights off between the
hours of 7am-7pm. This will be done so that the feeding time will be during the active
phase (“light off” phase) of the mice. Mice will be housed in Life Sciences in an area
that is currently used for studies of the circadian rhythm and therefore the light is wellregulated. After two weeks of entrainment, all but 8 mice will be switched to a Western
diet for four weeks, consisting of 45% fat with lard as the fat source. This additional
four week period of ad libitum feeding should allow for significant weight gain. Eight
mice will continue following a standard chow diet during this 4-week period and serve
as a low-fat control diet group. They will maintain this same diet throughout the entire
study period. Following the 4-week period, the mice fed the Western diet will be
divided into 6 additional groups: Western, CR, DR, TRF, ADF, and chow.

A MRI for the determination of body mass/fat and treadmill run to exhaustion will
occur at baseline (prior to starting the specific diet plan) and following eight weeks on
the specific diet assignment. Before and after the 4-week period of Western diet
feeding and at the end of the intervention period, a glucose tolerance test will be
performed. Mice will be fasted for 7 hours and glucose levels measured in 10 ul of
blood collected via the tail vein. Glucose will be administered intraperitoneally and
blood glucose measured every 30 minutes for 90 minutes from 10 ul of blood collected
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from the tail vein. At the end of the dietary intervention, prior to sacrifice, blood will
be collected from the facial vein for the determination of lipids, glucose, insulin,
oxidative stress markers, cytokines, immune cell populations, and other variables. All
mice will be sacrificed by CO2 inhalation. Tissues will be harvested immediately. This
form of euthanasia does not affect the outcome measures as determined by our
previous studies. Organs to be harvested are liver, spleen, intestine, lymph nodes,
adipose tissue, skeletal muscle, and heart.

B.

Describe IN DETAIL the procedures you will follow. Include accompanying

documentation and reference to previously published work in the box below. Provide a
complete bibliographic citation and describe any variations from the published technique.
The bibliography may be included in the box below or appended to this protocol.
Mice: 56, 4 week old C57BL/6 male mice will be purchased from Envigo or another
vendor. After arrival, mice will be co-housed (as done in reference 1) at the animal
facility on the University of Memphis campus.
After arrival at the University of Memphis, mice will be entrained under a 12h light:
12h dark schedule for two weeks with standard rodent chow available ad libitum.
During the entrainment period, the light-dark cycle will be reversed with lights off
between the hours of 7am-7pm. This will be done so that the feeding time will be
during the active phase (“light off” phase) of the mice. Mice will be housed in Life
Sciences in an area that is currently used for studies of the circadian rhythm and
therefore the light is well-regulated. After two weeks of entrainment, all but 8 mice
will be switched to a Western diet, consisting of 45% lard and 41% carbohydrate (20%
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sucrose, 9% corn starch, and 12% Maltodextrin). This additional four week period of
ad libitum feeding should allow for significant weight gain. Following this period,
mice will be divided into 6 additional groups and will consume their respective diets
for an additional 8 weeks.
Group 1 will have access to a standard rodent chow ad libitum, 24 hours per day.
Group 2 will have access to a purified, high-fiber, vegan-based diet ad libitum, 24
hours per day. We have used this same customized diet in past studies and it results in
normal weight/muscle mass gain, while minimizing fat accumulation. This will be the
DR arm of the trial.
Group 3 will have access to the Western diet ad libitum, 24 hours per day.
Group 4 will have ad libitum access to the Western diet for 6 hours at the beginning of
their active phase (7am-1pm). This will be the TRF arm of the trial. We have used this
exact feeding protocol in a recent investigation of mice. No negative health
consequences were observed using this protocol.
Group 5 will be on the alternate day fasting (ADF) protocol and have ad libitum access
to the Western diet every other day. That is, on day 1 they will have unrestricted access
to food during the entire 24 hour period. On day 2 they will receive no food. On day 3,
they will have unrestricted access to food, and so on. This same protocol has been
used in mice in several studies without incident. Please see references 2-10. It should
be noted that if the ADF protocol leads to significant weight loss beyond what would
be expected for mice following such a plan (≥20% body mass as compared to their
body mass at the start of the intervention period [after 4 weeks of following the ad
libitum Wester diet]) and/or mice show signs of stress or impaired health (e.g., scruffy
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coat, hunched posture, excessively aggressive behavior), the attending veterinarian will
be notified and a rescue protocol will be set in place and will consist of the following:
instead of receiving no food on the fasting days, mice will receive 20% of the daily
calories in the form of the Western diet during a one hour period at the mid-point of the
animals’ active phase (12-1pm).
It should be noted that animals in all groups will be monitored daily for signs of stress
and impaired health, with particular attention given to animals in the ADF group.
Monitoring body weight three times weekly should be more than adequate and should
not cause undue stress to the animals due to frequency of handling.
Group 6 will receive 80% of ad libitum intake of the Western diet as determined during
the prior 4 week period. This will be the CR arm of the trial. Multiple rodent studies
have reduced caloric intake by 20-40% without incident. See references 5 and 11-17.
Al mice will be monitored daily for sign of malnutrition and stress.
The diets will be purchased from Research Diets, which has experience in producing
the Western diet and purified vegan diets for rodent studies. The mice will remain on
their particular diets for eight weeks and then post-testing will begin. Mice will
continue on their diets until all testing is completed (~ end of week 9). Water will be
provided ad libitum throughout the study period. The amount of food consumed will be
measured daily and the weights of the mice will be taken three times per week at the
same time of day. There will be a total of 56 mice assigned in this study.
There will be two mice housed per cage. From our previous studies we know that
genetically similar mice eat basically a constant volume of food. We can therefore pairhouse the mice and determine an average amount of food consumed. Previous studies
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have used a similar set up where 3-5 mice were co-housed (Hatori et al.). If there are
any signs of fighting or it appears that one the mice is consuming the majority of the
food, those specific mice will be separated into individual cages. Food will be weighed
daily. Mice will be weighed 3 times per week at the same time of day. A glucose
tolerance test (GTT) will be performed at the beginning of the experiment (when mice
are put on their respective diets) and following 8 weeks after the start of the dietary
intervention. The final GTT will be performed 48h prior to euthanasia. For the glucose
tolerance test, mice will be fasted for a minimum of 7 hours and blood glucose levels
determined by blood from tail vein. Mice will be given a 1g glucose/kg body weight
intraperitoneally and blood (10ul) collected every 30 minutes for 90 minutes to
measure glucose levels. For blood collection, mice will be placed on a flat surface and
restraint by gently holding onto the tail without pulling. The tip of the tail will be
snipped – 1mm region. This part of the tail has little nerve innervation and does not
cause the animal any distress. By “milking” the tail, blood can be collected at multiple
time points without having to cut again. Isoflurane cannot be used as it increases blood
glucose levels independent of treatment. We have used this exact procedure in a recent
study.
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In addition to the GTT, prior to commencing the specific diet plans (after the initial 4
week period on the Western diet), animals will undergo a MRI for determination of body
mass/body fat. Body composition will be determined using an EchoMRI™ 1100. The
MRI is housed in room 115 in Life Sciences, the same location that our mice are housed
in. For scanning, animal are placed with cylindrical tube holders and movement restricted
to the bottom 7.5 cm as stated in the instrument manual and the study by Jones et al.
(Validation of quantitative resonance for the determination of body composition of mice.
Int. J Body Compos Res. 2009; 7(2):68-72). The animals are scanned without anesthesia,
sedation or restraint and are free to move within the holder. The smallest possible holder
is used to limit the movement of the mouse (without constraining them) in order to
reduce measurement errors induced by motion. Scanning time is approximately 40
seconds. There is no prior training required for the animal. We have prior experience
using this system in mice.

Finally, animals will undergo a treadmill run test to exhaustion using a motorized
treadmill without incline. Specifically, mice will be acclimated to the treadmill prior to
testing. Run to fatigue test will be performed twice in the mice; once prior to starting
the 8 week intervention and at the end of the 8 week intervention. Animals will run
using a 5% grade at 20m/min for 30 min and 25m/min for the remaining time until they
reach exhaustion. A warm up phase will be provided for 15min (5min at 5m/min, 5min
at 10m/min, 5min at 15m/min). Fatigue will be defined as the time at which mice are
no longer able or willing to keep up with the speed of the treadmill despite gentle hand
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prodding for a period of 30 seconds. Very mild electric shock will only be used if mice
do not respond well to gentle hand prodding. Our past and current work using running
protocols demonstrates that mild shocking is preferable to obtain the best running
performance. The frequency and amplitude of shock will be as low as possible to
motivate the animals to remain on the treadmill belt, without causing unnecessary
distress. We have used small electric shock in prior studies and this is well-accepted in
rodent running studies. Equipment will be cleaned upon the completion of testing with
ethanol solution. All urine and feces will be cleaned off of the device and the
surrounding area.
After 8-9 weeks of dietary intervention, mice will be euthanized (CO2 inhalation) and
with cervical dislocation. Tissues will be harvested immediately. This form of
euthanasia does not affect the outcome measures as determined by our previous
studies. Organs to be harvested are liver, spleen, intestine, lymph nodes, adipose tissue,
skeletal muscle, and heart. Immediately prior to euthanasia, blood will be collected via
the facial vein to measure lipids, glucose, insulin, oxidative stress markers, cytokines,
immune cell populations, and other variables as needed. Cecum and intestinal contents
will be collected for microbiome analysis.
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C.

Rationale for Involving Animals and the Appropriateness of Species and Number Used.

Indicate (here) briefly the short and/or long-term benefits (to humans and/or other
animals) of this use of animals for research, teaching or demonstration. Provide rational
for and the number of animals to be used. In addition, state briefly why living animals
are required for this study, rather than some alternative model.
The goal of this experiment is to study common feeding patterns in a controlled
environment over a moderate period of time to determine the cardio-metabolic health
effects of these dietary plans. Results will provide evidence for or against certain
models that can then be used by human subjects in an attempt to combat obesity and
related co-morbidities. We know from our prior work in rodents that the TRF and DR
models are favorable as compared to a WD. However, we are uncertain as to how CR
and ADF plans compare. Moreover, we are unaware of studies focused on comparing
these plans with regards to the microbiome or physical performance. These are
important areas of interest to scientists and humans who are focused on which dietary
plan may be “best.” As obesity is becoming more of a problem in the Western world,
determining which dietary approaches may be best to combat this disease is of great
importance.
The C57BL/6 diet induced obesity mouse model has been used previously to study the
effect of excess weight on various organ systems. As we are interested in the
interaction between the immune system, oxidative stress, physical performance, and
other organs, we cannot use isolated cell lines or model organisms such as yeast.
Additionally, many reagents have been developed for the use of mouse tissues,
especially antibodies that will be used to identify certain outcome measures. As we are
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focusing on the effect of the different dietary programs on multiple organ systems, it is
only feasible in an animal study.
There will be 8 mice per group for a total of 56 mice. This number is the norm for
similar studies of dietary-induced changes in our health-specific parameters. This
number should be sufficient to determine statistical significance for the tests planned
during this study.
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D.

Do the procedures described in B above, have the potential to inflict more
than momentary pain or distress (this does not include pain caused by
injections or other minor procedures)?

Yes

No
I have considered alternatives to procedures that might cause more than momentary or
slight pain/distress, and I have not found such alternatives. As such, I have used one or
more of the following methods and sources to search for such alternatives: (check below
each method used)

Agricola Data Base

Medline Data Base

CAB Abstracts

TOXLINE

BIOSIS

Lab. Animal Sci.

Lab Animal

Animal Welfare Info

Journal
Lab. Animals Journal
Center
ATLA (Alternatives to Laboratory Animal Journal)

Quick Biblio. Series

Lab Animal Welfare Bibliography (QL55L27311988)

"Benchmarks"

"Alternatives to Animal Use in Research, Testing and Education"
Current Contents
CARL
Direct contact with colleagues (if selected, you MUST document this below)
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List search words for the literature search:
Daniel Fast, dietary restriction, vegan fasting, fasting, time restricted feeding, intermittent
fasting, caloric restriction, alternate day fasting, chow, obesity, inflammation, oxidative
stress, microbiome, treadmill test, EchoMRI, insulin resistance, insulin sensitivity, fatty
acids, body composition, glucose, insulin, blood sugar (words used in isolated and in
combination in PubMed and Google Scholar).

What is the length of time that the literature search covers?
1960-2017
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III. Animal Use
A.

List all animal species to be used (example below).
Species Number1

Age2

Sex2

Weight2

Where Housed
(Bldg./Rm#)

e.g. Hooded
45

2 months

male

250-350 gm

Psychology Bld./422I

56

4 weeks

Male

15-20 gm

Life Sciences/115

Wistar rats
C57Bl/6 mice

1Individuals

using ectotherms need to only approximate numbers.

2Individuals

using fish or other ectotherms need not answer this question.

Is any species threatened or endangered?

Yes

No
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B.

Source of animals
Commercial vendor (Source___ Envigo

Labs_____________________________________________)
Bred at The University of Memphis
Captured from wild. Identify method of capture:
Transferred from another study (IACUC Protocol Number
Donated (Source

)

Tennessee Wildlife Resources Agency
Is the supplier a USDA approved source?

Yes

No
If not, explain why:
Animals are already in residence at U of M

C.

Will surgery be conducted on animals?

Yes

No
If yes, complete this section:
Non Recovery Surgery

Recovery Surgery

Multiple Survival Surgery (if the latter is checked, complete section F)

Surgeon(s) (Name/Job/Title/Academic Rank)
Room #)
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Location of Surgery (Bldg. &

D.

Will Anesthetic(s), Analgesic(s), or
Tranquilizing agents be administered?

Yes

No x
If yes, complete this section (example below).
Species & Sex

Agent

Dose Route Performed by
(Name/Title/Academic

Rank)
e.g. male Hooded

sodium

50

i.p

Mr. Smith/Research

Wistar rats

pentobarbitol

mg/kg

.

Technician/B.S.
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E.

Will euthanasia be carried out?

Yes

No

If yes, complete this section (example below).
Species & Sex Agent Dose Route Performed by (Name/Title/Academic Rank)
e.g. male Hooded

sodium

150

i.p

Mr. Smith/Research

Wistar rats

pentobarbitol

mg/kg

.

Technician/B.S.

C57BL/6 mice

CO2

3L/min

In

Marie van der Merwe/

ha

Assistant Professor

lat

Matt Butawan/Research

io

Associate

n

Sunita Sharma/Master’s
Student (Will be trained by
Dr. Karyl Buddington)

If no, describe disposition of animal(s) at conclusion of this study in box below.
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F.

Will special housing, conditioning, diets or other conditions
be required?

Yes

No
If yes, please explain in box below.
Mice will be on high fat, chow, or purified diets. Some mice will have restricted access
to food, either 7am-1pm or every other day. Some mice will have access to only 80%
of their daily ad libitum intake.

G.

Will animals be removed from the U of M campus at any time?

Yes

No

If yes, please indicate to where and for how long in box below.

H.

If they are to be housed for more than 24 hours outside approved facilities at U of

M, provide a scientific justification in box below.
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IV. Toxic and Hazardous Substances
A.

Check off any of the following below that will be used in these experiments?
Infectious agents (Fill out a, b)
Radioisotopes (Fill out a, b, e)
Toxic chemicals or carcinogens (Fill out a, b)
Recombinant DNA (Fill out a)
Experimental drugs (Fill out a)
Malignant cells or hybridomas (Fill out a, c)
Adjuvants (Fill out a)
Controlled substances (Fill out a, d, e)

For each checked off category, answer the questions indicated below:
a.

Identify the substance(s) and completely describe their use, including how will be
injected or given to the animal(s):

b.

Describe all procedures necessary for personnel and animal safety including
biohazardous waste, carcass disposal and cage decontamination:

c.

If transplantable tumors or hybridoma cells are to be injected into the
animals, have the tissues/cells been tested for inadvertent contamination
by viruses or mycoplasma?

Yes

No
If yes, what was the result (indicate in box below).
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d.

In the box below, provide a complete list of these substances, and if their use is not
explicitly explained in the materials already provided, explain their use and role in
the research.

Provide DEA license # covering the use of these substances:
To whom (or what entity) is the license issued?
e.

Provide Radioisotope License Number:

To whom is the license issued?
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V.

Categories of Animal Experimentation Based Upon Level of Manipulation and

Pain: (check off each category that is applicable to this application)
A.

Animals will be involved in teaching, research, experiments or tests involving
no pain, distress, or use of pain-relieving drugs.

B.

Animals will be subject to mild stress only (e.g., food or water deprivation of
less than 24 hours for use in behavioral studies such as operant conditioning;
physical restraint for less than 30 minutes), and will not be subject to surgery,
painful stimuli, or any of the other conditions described below. Procedures
described in this protocol have the potential to inflict no more than momentary
or slight pain or distress on the animal(s)----that is, no pain in excess of that
caused by injections or other minor procedures such as blood sampling.

C.

Animals will have minor procedures performed, blood sampling, etc. while

anesthetized.
D.

Live animals will be humanely killed without any treatments, manipulations,
etc. but will be used to obtain tissue, cells, sera, etc.

E.

Live animals will have significant manipulations, surgery, etc. performed
while anesthetized. The animals will be humanely killed at experiment
termination without regaining consciousness.

F.

Live animals will receive a painful stimulus of short duration without
anesthesia (behavior experiments with flight or avoidance reactions--e.g.,
shock/reward) resulting in a short-term traumatic response. Other examples in
this category are, blood sampling, injections of adjuvants, or drugs, etc.

Injection for glucose tolerance test; possible low grade shock while on treadmill.
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G.

Live animals will have significant manipulations performed, such as surgery,
while anesthetized and allowed to recover. Such procedures cause postanesthetic pain/discomfort resulting from the experiment protocol (e.g.,
chronic catheters. surgical wounds, implants) which cause a minimum of pain
and/or distress. Also included are mild toxic drugs or chemicals, tumor
implants (including hybridomas). tethered animals, short-termed physically
restrained animals (up to 1 hour), mother/infant separations.

H.

Live animals will have significant manipulations or severe discomfort, etc.
without benefit of anesthesia, analgesics or tranquilizers. Examples to be
included in this category are: toxicity testing, radiation sickness, irritants,
burns, trauma, biologic toxins, virulence challenge, prolonged: restrictions of
food or water intake, cold exposure, physical restraint or drug addiction. All
use of paralytic agents (curare-like drugs) must be included in this category.
Describe any abnormal environmental conditions that may be imposed.
Describe and justify the use of any physical restrain devices employed longer
then 1 hour.
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VI. Justifications for Category G Studies and Deviations from Standard
Techniques
Describe in the box below any steps to be taken to monitor potential or overt pain and/or
distress during the course of this study and how such pain or distress will be alleviated.
Be as detailed as necessary to justify your procedure.

VII. Certifications
(By submitting this protocol, I am acknowledging that I comply with the
certifications included in Section VII.) (check one)
Animal Use for Research. I certify that the above statements are true and the
protocol stands as the original or is essentially the same as found in the grant
application or program/project. The IACUC will be notified of any changes in the
proposed project, or personnel, relative to this application, prior to proceeding with
any animal experimentation. I will not purchase animals nor proceed with animal
experimentation until approval by the IACUC is granted.
Animal Use for Teaching/Demonstration. I certify that the information in this
application is essentially the same as contained in the course outline and a copy of
the laboratory exercises using animals is on file in the IACUC office. The IACUC
will be notified of any changes in the proposed project, or personnel, relative to this
application, prior to proceeding with any animal experimentation. I will not proceed
with animal experimentation until approval by the IACUC is granted.
Estimate the cost of maintaining animals used in this protocol based on current per diem
charge at University of Memphis.
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$7.20/day ($0.24/cage/day)

Please specify cost per unit of time:
$756 (15 weeks)

Specify anticipated total costs for project duration:

As supervisor of this project it is required that you inform your department chair
concerning any animal per diem costs related to this project that are to be paid by
the department.

By submitting this protocol, the Principal Investigator/Course Director indicates
that the following have been considered:

1.

Alternatives to use of animals.

2.

Reduction of pain and stress in animals to the lowest level possible.

3.

The proper needs of the animals with respect to housing and care.

4.

The lowest number of animals used that will give the appropriate experimental
results.

5.

Use of the most primitive species that will give the appropriate experimental results.

6.

Proper training of all personnel in the care and handling of the species used and in
the procedures called for in this protocol before beginning the experiment/teaching
or demonstration.
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7.

That this protocol is not an unnecessary repeat of results already in the literature or
in the case of teaching/demonstrations, results that can be demonstrated using
models or video material.
Marie van der Merwe/Richard Bloomer

Principal Investigator/Course Director (Type Name)

mvndrmrw@memphis.edu / rbloomer@memphis.edu

e-mail address

5/3/2017

Date
Federal Law requires that members of the IACUC be given adequate time to read and
review protocols including any changes or revisions in them.

Pre-review of protocols by the Attending Veterinarian is required before submission to
the IACUC. New protocols or modifications or renewals to protocols must be submitted
to the IACUC Chair by the 1st business day of the month to be considered for review
during that month. Incomplete protocols will be returned to the principal investigator.

E-mail the completed protocol to the IACUC Chair, Dr. Amy de Jongh Curry,
adejongh@memphis.edu

February, 2015
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